viral
infect
caus
numer
diseas
death
worldwid
due
emerg
new
virus
frequent
viru
variat
convent
antivir
strategi
directli
target
viral
cellular
protein
limit
specif
drug
resist
rapid
clearanc
human
bodi
therefor
develop
safe
potent
antivir
agent
activ
viral
infect
multipl
point
viral
life
cycl
remain
major
challeng
report
propos
new
modal
inhibit
viral
infect
fabric
dna
conjug
gold
nanoparticl
dnaaunp
network
cell
membran
protect
barrier
dnaaunp
network
found
via
plaqu
format
assay
viral
titer
potent
antivir
abil
protect
host
cell
human
respiratori
syncyti
viru
rsv
confoc
immunofluoresc
imag
analysi
show
viral
attach
viral
entri
viral
bud
inhibit
dnaaunp
network
confirm
realtim
fluoresc
imag
rsv
infect
process
antivir
activ
network
may
attribut
steric
effect
disrupt
membran
glycoprotein
limit
fusion
cell
membran
bilay
play
import
role
viral
infect
therefor
result
suggest
dnaaunp
network
prophylact
effect
inhibit
viru
attach
entri
also
therapeut
effect
inhibit
viral
bud
celltocel
spread
importantli
proofofprincipl
studi
provid
pathway
develop
univers
broadspectrum
antivir
therapi
biomateri
j
u
r
n
l
h
e
p
g
e
w
w
w
e
l
se
v
e
r
co
lo
ca
e
b
e
ri
l
http
dx
viral
infect
one
lead
caus
human
diseas
death
pose
signific
global
health
challeng
especi
emerg
new
virus
frequent
viru
variat
convent
antivir
therapi
greatli
limit
clinic
applic
specif
target
drug
resist
advers
side
effect
associ
prolong
use
furthermor
still
safe
effect
vaccin
avail
today
press
viral
pathogen
includ
recent
detect
virus
middl
east
respiratori
syndromecoronaviru
merscov
caus
sever
acut
respiratori
ill
high
mortal
rate
among
peopl
anim
therefor
effort
develop
safe
effect
potent
altern
convent
antivir
therapi
pathogen
viral
infect
becom
urgent
public
health
viral
infect
usual
follow
three
step
name
initi
attach
entri
virus
host
cell
follow
genom
releas
replic
protein
synthesi
final
releas
new
virion
target
earli
step
viral
attach
entri
popular
strategi
viral
inhibit
extracellular
site
action
inhibitor
rel
access
gener
earli
step
involv
recognit
receptor
host
cell
surfac
viral
envelop
glycoprotein
therefor
one
wide
use
strategi
pursu
develop
antivir
therapi
interfer
recognit
event
therebi
block
viral
entri
cell
present
two
gener
approach
adopt
achiev
goal
one
target
viral
protein
target
cellular
protein
target
viral
protein
seri
peptid
nanomateri
develop
mimic
cellular
receptor
compet
viral
bind
cell
approach
wide
report
sinc
bind
virus
thu
sequest
infecti
agent
within
extracellular
environ
howev
antivir
therapi
usual
activ
specif
virus
make
difficult
develop
broadspectrum
antivir
addit
approach
also
hamper
inextric
challeng
drug
resist
rapid
clearanc
via
bodili
fluid
target
cellular
protein
oppos
mechan
gener
adopt
mask
host
cell
bind
site
approach
may
afford
antivir
compound
prolong
period
broader
spectrum
activ
possibl
decreas
chanc
drug
resist
howev
target
host
cell
may
result
toxic
protein
pathway
use
might
crucial
cell
surviv
overal
two
antivir
approach
outlin
hinder
potenti
drug
resist
rapid
clearanc
bodi
fluid
interfer
physiolog
cellular
signal
cascad
consequ
cellular
respons
pathogen
specif
thu
use
virus
known
receptor
solv
problem
herein
propos
novel
antivir
strategi
involv
fabric
dnaconjug
gold
nanoparticl
dnaaunp
network
host
cell
membran
may
act
protect
barrier
effici
prevent
viral
attach
entri
bud
feasibl
process
inhibit
viral
infect
support
two
aspect
one
hand
nanoscal
materi
recent
emerg
novel
antivir
agent
due
high
surfac
area
volum
ratio
uniqu
chemic
physic
properti
nanoparticlebound
ligand
found
enhanc
interact
target
molecul
spatial
orient
multival
conjug
thu
nanomedicin
open
new
avenu
prevent
viral
infect
improv
treatment
success
rate
hand
report
viral
entri
inhibit
block
bind
viru
target
receptor
cell
surfac
also
interf
abil
viral
fusion
protein
alter
mechan
properti
membran
lipid
bilay
make
bilay
less
suscept
viral
fusion
demonstr
feasibl
approach
human
respiratori
syncyti
viru
rsv
host
cell
human
epidermi
larynx
carcinoma
cell
line
cell
use
test
system
rsv
envelop
rna
viru
import
respiratori
pathogen
infant
young
children
caus
lower
respiratori
tract
infect
present
approv
vaccin
rsv
specif
interact
viral
envelop
glycoprotein
cell
surfac
receptor
remain
unclear
thu
difficult
use
convent
antivir
bind
directli
viral
protein
cellular
protein
inhibit
viru
infect
consid
dnaaunp
network
bind
directli
viral
protein
specif
domain
cell
surfac
protein
would
expect
inhibit
viru
infect
broadspectrum
antivir
abil
variou
virus
even
unknown
receptor
human
epidermi
larynx
carcinoma
cell
line
cell
normal
human
bronchial
epitheli
nhbe
cell
cultur
rpmi
hyclon
dmem
medium
respect
contain
wv
fetal
bovin
serum
fb
hyclon
uml
penicillin
g
mgml
streptomycin
sulfat
human
rsv
strain
long
guangzhou
biotest
bioengin
co
ltd
china
propag
monolay
cultur
cell
rpmi
cultur
medium
fb
c
co
day
postinfect
cytopath
effect
cpe
present
cell
subject
round
freezeethaw
cycl
releas
virion
cell
debri
remov
centrifug
g
c
min
harvest
rsv
store
c
dna
sequenc
aaa
ggg
tct
gag
gga
ttt
ttt
ttt
biottt
ttt
ttt
ttt
ttt
gtc
gtg
ggt
linker
dna
tcc
ctc
aga
ccc
ttt
peg
ag
acc
cac
gac
dna
sequenc
synthes
abi
dnarna
synthes
appli
biosystem
foster
citi
ca
usa
purif
esi
mass
spectrometri
character
dna
sequenc
finish
sangon
shanghai
china
linker
dna
purifi
character
takara
dalian
china
see
fig
ref
crosslink
dnananoparticl
network
cell
membran
involv
three
step
cell
cultur
rpmi
medium
supplement
fb
c
co
h
cell
wash
three
time
cold
pb
biotinyl
mgml
biotinyl
reagent
sulfonhslclcbiotin
thermo
scientif
room
temperatur
min
wash
three
time
pb
ph
plu
mm
glycin
biotinyl
cell
incub
streptavidinco
gold
nanoparticl
saaunp
c
min
anchor
aunp
cell
membran
subsequ
wash
pb
biotin
function
conjug
aunp
c
min
specif
interact
streptavidin
biotin
excess
remov
three
wash
pb
final
form
dnaaunp
network
cell
membran
linker
dna
ad
hybrid
room
temperatur
h
aunp
conjug
bsa
bsaaunp
aunpssa
conjug
solut
use
control
plaqu
assay
cell
cell
ml
grown
plate
c
co
h
format
dnaaunp
network
cell
membran
infect
carri
ad
serial
dilut
rsv
cell
follow
incub
c
h
cell
treat
dnaaunp
network
cell
infect
rsv
use
control
wash
pb
cell
overlaid
ml
rpmi
cultur
medium
contain
fb
agar
incub
c
co
day
cell
fix
formaldehyd
pb
stain
ml
neutral
red
h
number
plaqu
clear
spot
calcul
wash
viral
titer
assay
cell
cell
ml
grown
plate
c
co
h
confluenc
cell
cultur
withwithout
fabric
dnaaunp
network
cell
membran
infect
rsv
moi
c
h
allow
complet
infect
cell
wash
pb
overlaid
ml
rpmi
cultur
medium
fb
incub
h
cultur
media
collect
frozen
c
follow
defrost
room
temperatur
freezeethaw
cycl
repeat
three
time
fresh
cell
cultur
grown
plate
infect
serial
dilut
viru
suspens
titrat
sampl
infect
cell
cultur
rpmi
cultur
medium
fb
c
co
day
tcid
calcul
accord
reedemuench
formula
cell
viabil
assay
cell
cell
ml
cultur
plate
c
co
h
rpmi
medium
contain
fb
pb
wash
dnaaunp
network
anchor
cell
membran
cell
incub
rsv
moi
c
h
allow
viru
infect
wash
three
time
icecold
pb
remov
free
viru
infect
cell
maintain
rpmi
supplement
fb
co
incub
day
cell
without
dnaaunp
network
cell
membran
cell
infect
rsv
use
control
cytotox
examin
use
cell
viabil
assay
base
optic
densiti
od
measur
nm
biotek
micropl
reader
usa
cell
nhbe
cell
cell
ml
cultur
mm
glassbottom
cell
cultur
dish
nest
corp
h
investig
whether
rsv
attach
inhibit
dnaaunp
network
dnaaunp
network
first
anchor
cell
membran
rsv
ad
cell
moi
follow
incub
c
min
control
experi
perform
incub
rsv
cell
c
min
first
form
dnaaunp
network
cell
membran
addit
doseerespons
studi
carri
investig
relationship
inhibit
effici
viral
attach
amount
aunp
use
nm
nm
valid
inhibit
viral
entri
dnaaunp
network
neglig
effect
intern
dnaaunp
network
anoth
experi
perform
cell
anchor
dnaaunp
network
incub
c
h
h
h
h
follow
rsv
infect
time
point
incub
cell
cultur
medium
fb
c
day
three
wash
icecold
pb
cell
fix
paraformaldehyd
min
nonspecif
bind
site
block
bsa
h
cell
incub
mous
monoclon
antibodi
rsv
envelop
protein
g
abcam
c
h
final
dylight
goat
antimous
igg
thermo
scientif
ad
incub
cell
c
h
step
follow
wash
three
time
icecold
pb
fluoresc
imag
acquir
use
olympu
invert
microscop
equip
olympu
confoc
scan
system
roleramgi
emccd
coloc
analysi
perform
imagepro
plu
softwar
dylight
excit
nm
detect
nm
barrier
filter
investig
whether
viral
bud
differ
time
point
could
inhibit
dnaaunp
network
viru
infect
carri
firstli
incub
cell
rsv
moi
c
h
h
h
dnaaunp
network
anchor
cell
membran
wash
two
time
pb
cell
incub
c
day
follow
immunofluoresc
imag
comparison
similar
treatment
perform
cell
cultur
infect
rsv
treat
dnaaunp
network
cell
cell
ml
cultur
mm
glassbottom
cell
cultur
dish
nest
corp
h
imag
inhibit
rsv
attach
cell
realtim
cell
without
dnaaunp
network
incub
qdsrsv
follow
livecel
imag
conduct
use
timelaps
spin
confoc
microscopi
min
see
movi
ref
imag
inhibit
rsv
entri
cell
realtim
cell
without
dnaaunp
network
firstli
incub
qdsrsv
c
h
follow
livecel
imag
use
timelaps
spin
confoc
microscopi
min
see
movi
ref
fabric
dnaaunp
network
cell
membran
protect
barrier
viral
infect
involv
four
step
scheme
first
membran
protein
cell
biotinyl
treat
cell
biotinyl
reagent
contain
biotin
aminoreact
nh
provid
bind
site
anchor
streptavidinfunction
nanoparticl
time
saaunp
prepar
modifi
aunp
nm
sa
block
bioactiv
site
bsa
process
monitor
measur
optic
featur
hydrodynam
diamet
zeta
potenti
aunp
see
fig
ref
saaunp
anchor
cell
surfac
interact
sa
biotinyl
glycoprotein
thirdli
two
biotinmodifi
oligonucleotid
name
immobil
saaunp
previous
identifi
solut
measur
hydrodynam
diamet
zeta
potenti
see
fig
ref
final
hybrid
perform
presenc
linker
dna
partial
complementari
two
sequenc
immobil
surfac
aunp
result
neighbor
aunp
may
interlock
multipl
short
duplex
segment
creat
network
structur
aunp
aggreg
cell
membran
dnaaunp
network
inhibit
abil
virus
attach
gain
entri
bud
cell
surfac
scheme
visual
success
anchor
dnaaunp
network
outer
cell
membran
imag
aunp
cell
membran
use
scan
electron
microscopi
sem
shown
fig
incub
h
nm
aunp
exist
cluster
cell
membran
may
due
movement
scheme
schemat
represent
format
dnaaunp
network
cell
membran
inhibit
behavior
viral
attach
entri
bud
crosslink
particl
along
dna
hybrid
cell
surfac
report
nanostructur
attach
cell
caus
cell
membran
curvatur
henc
tend
form
cluster
lower
elast
energi
membran
intern
dnaaunp
network
investig
incub
cell
c
differ
length
time
sem
imag
taken
h
h
incub
indic
dnaaunp
network
still
present
surfac
cell
attribut
simultan
bind
dnaaunp
network
larg
number
biotinyl
glycoprotein
cell
membran
form
rel
larg
network
sever
hundr
nanomet
thu
facilit
cluster
particl
reduc
rate
intern
order
determin
whether
crosslink
limit
small
particl
nm
aunp
also
test
form
dnaaunp
network
similar
abil
stabil
smaller
particl
demonstr
method
form
network
independ
particl
size
fig
owe
strong
light
scatter
local
surfac
plasmon
reson
lspr
properti
aunp
darkfield
microscopi
scatter
imag
techniqu
advantag
high
resolut
high
sensit
use
demonstr
format
dnaaunp
network
cell
membran
shown
fig
spot
light
scatter
signal
observ
cell
anchor
saaunp
aunp
conjug
addit
complementari
linker
dna
hybrid
occur
result
strong
plasmon
reson
coupl
within
aggreg
aunp
caus
enhanc
electromagnet
field
stronger
light
scatter
signal
among
region
contain
dnaaunp
network
process
lead
great
fluctuat
concentr
aunp
solut
thu
greatli
enhanc
light
scatter
observ
accord
einstein
fluctuat
theori
light
scatter
enhanc
electromagnet
field
could
confirm
modifi
fluoresc
dye
end
oligonucleotid
indic
confoc
fluoresc
microscopi
imag
see
fig
ref
sinc
singlestrand
oligonucleotid
flexibl
cell
membran
highli
dynam
fluid
fluoresc
quench
aunp
addit
linker
dna
subsequ
dna
hybrid
fluorophor
assum
exist
within
proxim
dnaaunp
network
distanc
nm
enhanc
electromagnet
field
result
enhanc
fluoresc
intens
observ
sinc
nobl
metal
nanoparticl
within
proper
distanc
fluoresc
tag
report
activ
tag
immobil
metal
surfac
fluoresc
enhanc
could
still
observ
even
incub
h
fig
ref
indic
stabil
reliabl
antivir
structur
consist
result
sem
stabil
construct
dnaaunp
network
degrad
digest
dnasei
confirm
agaros
gel
electrophoresi
imag
hydrodynam
diamet
measur
gel
electrophoresi
imag
fig
ref
show
dnaaunp
network
retain
around
sampl
well
digest
dnasei
attribut
larg
size
complex
stabil
enzymat
cleavag
time
neglect
size
chang
observ
dnaaunp
network
incub
dnasei
fig
ref
result
demonstr
compar
dna
sequenc
without
conjug
aunp
format
dnaaunp
network
inde
suffici
effici
provid
protect
enzymat
cleavag
firstli
investig
cytotox
dnaaunp
network
cell
membran
vitro
grow
cell
presenc
high
concentr
aunp
found
cell
show
high
cell
viabil
even
nm
aunp
indic
dnaaunp
network
excel
biocompat
cell
infect
rsv
f
protein
infect
cell
membran
new
bud
virion
may
fuse
neighbor
cell
form
syncytia
coalesc
syncytia
may
caus
format
area
cell
monolay
devoid
viabl
cell
due
virusinduc
lysi
plaqu
therefor
antivir
effici
dnaaunp
network
rsv
evalu
plaqu
format
assay
uninfect
cell
treat
dnaaunp
network
show
similar
monolay
morpholog
viabil
uninfect
cell
without
dnaaunp
fig
howev
infect
cell
cultur
treat
dnaaunp
network
show
typic
cytopath
effect
cpe
result
largescal
spread
infect
massiv
cell
destruct
contrast
viral
bud
celltocel
spread
viru
restrict
small
number
neighbor
cell
cell
destruct
reduc
infect
cell
cultur
treat
dnaaunp
network
illustr
potent
antivir
activ
network
shown
fig
light
column
cell
treat
dnaaunp
network
significantli
fewer
plaqu
wash
compar
untreat
cell
support
result
number
newli
produc
virion
infect
cell
determin
use
viral
titer
express
tissu
cultur
infecti
dose
tcid
shown
fig
dark
column
viral
infect
presenc
dnaaunp
network
tcid
ml
lower
viru
absenc
network
tcid
ml
thu
result
term
plaqu
number
viral
titer
confirm
strong
inhibitori
activ
dnaaunp
network
viral
infect
addit
illustr
fig
cell
viabil
h
postinfect
increas
host
cell
protect
advanc
dnaaunp
network
demonstr
abil
network
protect
rsv
infect
two
possibl
mode
could
independ
combin
account
antivir
activ
dnaaunp
network
one
inhibit
attach
entri
viru
cell
prophylact
effect
inhibit
viral
bud
celltocel
spread
therapeut
effect
known
viral
infect
begin
viral
attach
host
cell
membran
effect
block
first
step
signific
prophylact
effect
viral
diseas
therefor
block
viral
attach
stage
dnaaunp
network
first
investig
immunofluoresc
imag
cell
first
treat
dnaaunp
network
infect
rsv
moi
c
enabl
viru
attach
entri
cell
uninfect
cell
fig
ab
infect
cell
treat
dnaaunp
network
fig
cd
use
control
cell
immunostain
mous
monoclon
antibodi
rsv
protein
g
one
major
envelop
glycoprotein
rsv
assum
immunofluoresc
signal
intens
observ
cell
membran
proport
number
attach
virion
shown
fig
compar
cell
absenc
dnaaunp
network
signal
intens
cell
treat
first
network
infect
obvious
reduc
fig
ef
quantif
immunofluoresc
signal
intens
color
plot
use
imag
j
softwar
show
signal
intens
remain
cell
protect
dnaaunp
network
equat
inhibit
viral
attach
protect
barrier
owe
steric
effect
fig
howev
also
possibl
steric
effect
may
inhibit
attach
rsv
protein
g
antibodi
immunostain
result
reduc
immunofluoresc
signal
intens
exclud
possibl
control
experi
carri
infect
cell
prior
anchor
dnaaunp
network
immunostain
immunofluoresc
signal
intens
fig
gh
found
maintain
compar
infect
cell
treat
dnaaunp
network
prove
rsv
protein
g
antibodi
attach
would
inhibit
protect
barrier
suggest
reduc
immunofluoresc
signal
intens
fig
ef
inde
due
reduc
attach
viru
cell
protect
dnaaunp
network
result
explain
fact
viral
attach
usual
associ
receptor
lipid
raft
region
cell
membran
eg
glycoprotein
dnaaunp
network
bind
larg
number
biotinyl
glycoprotein
cell
membran
access
viral
envelop
glycoprotein
g
f
receptor
lipid
raft
would
inhibit
steric
effect
therebi
inhibit
viral
attach
sinc
block
entir
cell
membran
dnaaunp
network
long
time
might
advers
interfer
cellular
signal
pathway
essenti
cell
surviv
necessari
make
clear
percent
cell
membran
need
block
minim
dnaaunp
network
effici
prevent
viral
attach
cell
surfac
therefor
doseerespons
studi
carri
investig
relationship
inhibit
effici
viral
attach
amount
aunp
use
shown
fig
inhibit
effici
improv
gradual
increas
amount
aunp
calcul
nm
aunp
dosag
enough
inhibit
viral
attach
case
cell
membran
cover
dnaaunp
network
indic
construct
dnaaunp
network
exhibit
potent
effect
prevent
viral
attach
cell
surfac
consequ
one
third
cell
membran
need
block
minim
dnaaunp
network
obtain
desir
antivir
effect
attach
host
cell
rsv
entri
occur
fuse
lipid
bilay
viral
envelop
cellular
plasma
membran
helix
coiledcoil
bundl
f
protein
fusion
viruscel
may
prevent
steric
effect
dnaaunp
network
host
cell
membran
therebi
inhibit
viral
entri
thu
addit
proof
inhibit
viral
attach
entri
dnaaunp
network
preincub
cell
dnaaunp
network
follow
rsv
attach
incub
allow
penetr
viru
cell
two
day
cultiv
progeni
genom
protein
rsv
abundantli
produc
aggreg
close
cell
membran
therefor
newli
produc
virus
abl
bind
larg
number
antirsv
antibodi
henc
strong
immunofluoresc
signal
observ
unprotect
cell
indic
high
level
viru
replic
therebi
result
inocul
bud
fig
contrast
immunofluoresc
signal
intens
decreas
cell
infect
presenc
dnaaunp
network
fig
f
explor
effect
intern
dnaaunp
network
antivir
activ
network
form
cell
surfac
incub
c
h
h
h
h
follow
rsv
infect
moi
shown
fig
dnaaunp
network
reduc
viral
attach
entri
even
h
indic
intern
dnaaunp
network
neglig
effect
antivir
abil
exclud
possibl
reduc
immunofluoresc
signal
intens
due
toxic
aunp
viru
control
experi
perform
anchor
aunp
cell
surfac
absenc
linker
dna
allow
network
format
immunofluoresc
intens
reduc
compar
cell
infect
without
aunp
suggest
reduc
immunofluoresc
signal
result
inhibitori
effect
dnaaunp
network
addit
late
stage
rsv
infect
fusion
protein
f
surfac
infect
cell
newli
bud
virion
may
simpli
fuse
neighbor
cell
form
syncytia
result
obviou
cpe
indic
arrow
fig
ref
howev
cpe
obvious
reduc
cell
treat
postinfect
dnaaunp
network
indic
import
role
protect
barrier
viral
infect
ref
decreas
immunofluoresc
signal
intens
reduc
cpe
impli
dnaaunp
network
prevent
larg
proport
viral
attach
cell
surfac
entri
cell
therebi
inhibit
viru
replic
host
cell
result
shown
dnaaunp
network
inde
possess
prophylact
effect
rsv
infect
effect
block
viral
attach
entri
howev
clear
whether
network
also
gener
therapeut
effect
exist
infect
cell
infect
rsv
prior
anchor
dnaaunp
network
virion
nucleocapsid
may
success
releas
host
cell
cytoplasm
follow
synthesi
assembl
viral
protein
thu
new
virion
bud
plasma
membran
surfac
infect
cell
case
therapeut
treatment
antivir
agent
would
concentr
block
viral
bud
determin
whether
dnaaunp
abil
cell
first
infect
rsv
moi
h
h
h
treat
dnaaunp
network
follow
incub
day
process
rule
infect
unadsorb
virion
viral
bud
celltocel
spread
expect
continu
result
format
syncytia
result
cell
treat
dnaaunp
network
differ
time
point
show
significantli
lower
number
syncytia
reduc
immunofluoresc
signal
intens
compar
untreat
cell
fig
indic
even
cell
alreadi
infect
subsequ
treatment
dnaaunp
network
later
stage
still
effect
control
viral
bud
explain
follow
firstli
report
assembl
rsv
cell
occur
lipidraft
contain
high
level
regulatori
protein
incorpor
envelop
matur
viru
particl
secondli
bud
virion
cell
might
induc
chang
membran
curvatur
cluster
raft
spike
protein
involv
cooper
among
sever
protein
protein
conform
chang
cell
membran
furthermor
viral
bud
format
syncytia
involv
fusion
f
protein
cell
membran
possibl
newli
bud
virion
neighbor
cell
action
includ
assembl
bud
celltocel
spread
viru
relat
cell
membran
especi
function
glycoprotein
lipid
raft
howev
bind
dnaaunp
network
biotinyl
glycoprotein
may
induc
steric
effect
result
disrupt
cooper
make
lipid
bilay
cell
membran
less
suscept
fusion
therefor
assembl
bud
virion
host
cell
celltocel
spread
viru
particl
greatli
inhibit
result
even
though
cell
infect
earli
stage
subsequ
treatment
dnaaunp
network
cell
membran
may
also
inhibit
infect
alter
lipidraft
protein
scheme
demonstr
antivir
abil
dnaaunp
network
celldepend
next
evalu
inhibitori
effect
rsv
infect
primari
normal
human
bronchial
epitheli
nhbe
cell
confoc
immunofluoresc
imag
analysi
fig
show
viral
attach
viral
entri
viral
bud
inhibit
dnaaunp
network
cell
membran
result
compar
obtain
rsv
infect
cell
show
antivir
capac
dnaaunp
network
independ
celltyp
furthermor
nhbe
cell
protect
rsv
demonstr
dnaaunp
network
anchor
cell
membran
activ
inhibit
viral
infect
multipl
point
viral
life
cycl
monitor
block
rsv
infect
dnaaunp
network
cell
membran
realtim
rsv
label
semiconductor
quantum
dot
qdsrsv
qd
wide
use
fluoresc
tag
track
viral
infect
event
owe
superior
bright
photost
tradit
fluoresc
tag
label
strategi
perform
incub
biotinyl
rsv
qdot
streptavidin
conjug
qdssa
nm
red
fluoresc
qd
could
use
track
rsv
infect
process
rsv
attach
entri
cell
without
treatment
dnaaunp
network
monitor
livecel
imag
conduct
use
timelaps
spin
confoc
microscopi
min
movi
pictur
display
obviou
red
fluoresc
qd
gather
membran
cell
treat
dnaaunp
network
indic
larg
number
virus
came
close
attach
cellular
membran
fig
movi
ref
left
side
interest
note
virion
abl
attach
cell
surfac
within
min
chang
significantli
min
cours
observ
impli
invas
process
rapid
contrast
virus
observ
cellular
membran
cell
treat
dnaaunp
network
demonstr
major
virion
effect
block
protect
barrier
cell
membran
fig
movi
ref
right
side
furthermor
even
incub
rsv
cell
c
h
movi
show
fewer
intracellular
red
fluoresc
dot
cell
previous
protect
dnaaunp
network
indic
entranc
intern
rsv
cell
effect
inhibit
fig
movi
ref
abil
dnaaunp
inhibit
attach
entri
quantifi
manual
count
observ
red
dot
shown
fig
averag
number
rsv
per
cell
correspond
viral
attach
reduc
light
column
cell
protect
dnaaunp
network
agreement
calcul
immunofluoresc
imag
meanwhil
viral
entri
calcul
reduc
dark
column
also
accord
result
immunofluoresc
imag
thu
decreas
averag
number
rsv
per
cell
reveal
realtim
imag
prove
anchor
dnaaunp
network
cell
membran
inde
effect
block
attach
entranc
rsv
cell
sinc
antivir
strategi
propos
target
neither
viral
protein
cellular
protein
applic
strategi
differ
nanoparticl
need
investig
firstli
sa
fig
confoc
immunofluoresc
imag
biotinyl
nhbe
cell
inhibit
viral
attach
entri
bud
dnaaunp
network
quantif
immunofluoresc
signal
intens
viral
attach
inhibit
carri
fabric
dnaaunp
network
cell
surfac
follow
infect
rsv
c
min
viral
entri
inhibit
b
involv
incub
infect
cell
c
day
viral
bud
inhibit
experi
c
perform
infect
cell
cultur
rsv
c
h
fabric
dnaaunp
network
cell
membran
wash
cell
incub
c
day
mous
monoclon
antibodi
rsv
protein
g
goat
antimous
igg
dylight
use
immunofluoresc
assay
error
bar
repres
standard
deviat
three
replic
experi
cpe
indic
arrow
cell
cell
ml
aunp
nm
moi
linker
dna
mm
rsv
moi
scale
bar
mm
function
magnet
nanoparticl
samnp
nm
use
form
dnamagnet
nanoparticl
dnamnp
network
crosslink
aggreg
mnp
conjug
solut
shown
tem
fig
ref
increas
hydrodynam
diamet
measur
fig
ref
success
anchor
dnamnp
network
cell
membran
observ
sem
fig
ref
show
similar
behavior
dnaaunp
network
abil
inhibit
viru
infect
also
demonstr
immunofluoresc
imag
fig
ref
show
viral
attach
reduc
cell
cover
dnamnp
network
indic
biocompat
mnp
also
potenti
use
antivir
agent
gener
antivir
strategi
confirm
form
six
type
dnananoparticl
network
cell
membran
aunp
nm
nm
nm
mnp
nm
nm
silver
nanoparticl
agnp
nm
biocompat
antivir
abil
differ
dnananoparticl
network
investig
compar
cell
viabil
cell
infect
rsv
shown
fig
ref
except
nm
aunp
nm
agnp
dnananoparticl
network
remain
four
type
dnananoparticl
network
anchor
cell
membran
affect
cell
viabil
infect
rsv
cell
protect
four
type
network
show
higher
cell
viabil
cell
infect
absenc
indic
four
type
dnananoparticl
network
nm
nm
aunp
nm
nm
mnp
anchor
cell
membran
inhibit
viral
infect
relationship
dnananoparticl
composit
size
surfac
coat
effect
biocompat
antivir
activ
requir
work
fulli
defin
aim
tune
paramet
achiev
satisfactori
biocompat
antivir
abil
therebi
select
best
antivir
agent
summari
develop
novel
antivir
strategi
fabric
dnaaunp
network
host
cell
membran
act
protect
barrier
inhibit
viral
infect
block
attach
entri
viru
andor
inhibit
viral
bud
celltocel
spread
antivir
efficaci
dnaaunp
network
evalu
plaqu
format
assay
viral
titer
immunofluoresc
imag
realtim
imag
method
offer
sever
attract
featur
dnaaunp
network
abl
anchor
host
cell
membran
good
biocompat
stabil
exhibit
ideal
antivir
activ
dnaaunp
network
may
abl
design
prophylact
well
therapeut
activ
viral
infect
proofofprincipl
studi
provid
promis
approach
altern
standard
antivir
therapi
act
multipl
point
viral
life
cycl
sinc
dnaaunp
network
pathogen
specif
potenti
develop
broadspectrum
antivir
agent
virus
differ
famili
especi
unforeseen
viral
epidem
pandem
difficult
treat
tradit
antivir
therapi
howev
say
proofofprincipl
studi
still
far
away
clinic
set
futur
vivo
studi
aim
evalu
prophylact
therapeut
promis
present
cellular
level
proofofconcept
studi
need
carri
use
appropri
anim
model
meantim
seri
problem
need
consid
doseerespons
relationship
dnaaunp
network
transfer
target
cell
get
remov
viral
threat
remov
number
research
still
way
find
answer
report
engin
nanomateri
make
use
lung
gastrointestin
tract
port
entri
bodi
treatment
lower
respiratori
tract
infect
inhal
therapi
may
altern
transfer
nanodrug
cell
therapi
nanoparticl
might
taken
macrophag
lung
elimin
organ
normal
clearanc
process
andor
excret
faec
care
analysi
doseerespons
relationship
greatli
need
risk
assess
improv
biosafeti
anyhow
envis
uniqu
antivir
mechan
may
lead
develop
new
strategi
agent
combat
viral
diseas
improv
treatment
viral
infect
